This Article Full Text (PDF) All Versions of this Article: 1352458508101951v1 15/5/593    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zéphir, H Articles by Vermersch, P Search for Related Content PubMed PubMed Citation Articles by Zéphir, H Articles by Vermersch, P Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis

Pôle Neurologique, Hôpital Roger Salengro, CHRU de Lille, Lille, France; Laboratoire d’Immunologie, EA 2686, Université de Lille II, Lille, France

D Lefranc

Laboratoire d’Immunologie, EA 2686, Université de Lille II, Lille, France

S Dubucquoi

Laboratoire d’Immunologie, EA 2686, Université de Lille II, Lille, France

J de Seze

Service de Neurologie, Hôpitaux universitaires de Strasbourg, Strasbourg, France

L Boron

Laboratoire d’Immunologie, EA 2686, Université de Lille II, Lille, France

L Prin

Laboratoire d’Immunologie, EA 2686, Université de Lille II, Lille, France

P Vermersch

Pôle Neurologique, Hôpital Roger Salengro, CHRU de Lille, Lille, France; Laboratoire d’Immunologie, EA 2686, Université de Lille II, Lille, France

Objective

We previously showed that serum IgG repertoires distinguished multiple sclerosis (MS) patients from healthy subjects and from patients with other inflammatory neurological diseases (OIND). We questioned whether the serum IgG repertoire of patients presenting a clinically isolated syndrome (CIS) could predict MS.

Methods

The global IgG immune responses against brain antigens in sera from 50 CIS patients were evaluated by immunoblotting. The IgG reactivities were compared with those from MS sera (n = 82), healthy sera (n = 27), and sera from OIND (n = 42). A linear discriminant analysis (LDA) defined a score for each individual.

Results

About 78% of scores obtained from CIS patients were located in the "MS area." During the follow-up (3.5 ± 1.3 years), 28 patients fulfilled the McDonald criteria for MS, 15 patients remained CIS, and 7 patients developed OIND. Among the patients with an LDA score in the "MS area," 61.5% converted to MS.

Discussion

Our results suggest that a pathological distortion of the self-reactive IgG repertoire occurs early so that immunomodulating treatment should be started as early as possible; they also highlight the early involvement of B cells in the physiopathological process in MS.

Key Words: B cells • biomarker • CIS • IgG • immunology • multiple sclerosis

This version was published on May 1, 2009

Multiple Sclerosis, Vol. 15, No. 5, 593-600 (2009)
DOI: 10.1177/1352458508101951


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?